Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment

PURPOSE: The approval of immune checkpoint inhibitors for metastatic non-small-cell lung carcinomas (mNSCLC) treatment has presented more care options. Therefore, it is important to identify the benefit-risk trade-offs patients and caregivers are willing to make among potential treatment options. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yong, Candice, Cambron-Mellott, M Janelle, Seal, Brian, Will, Oliver, Maculaitis, Martine C, Clapp, Kelly, Mulvihill, Emily, Cotarla, Ion, Mehra, Ranee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769053/
https://www.ncbi.nlm.nih.gov/pubmed/35068928
http://dx.doi.org/10.2147/PPA.S338840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769053/
https://www.ncbi.nlm.nih.gov/pubmed/35068928
http://dx.doi.org/10.2147/PPA.S338840

Ejemplares similares